Merit Medical Systems, Inc. (NASDAQ:MMSI) is reporting third quarter financial results on Wednesday 28th October 2020, after market close.
According to analysts surveyed by Thomson Reuters, MMSI is expected to report 3Q20 income of $ 0.20 per share from revenue of $ 216.31 million.
For the full year, analysts anticipate top line of $ 938.79 million, while looking forward to income of $ 1.29 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,044.00 million ~ $ 1,064.00 million, where as bottomline are predicted in a range of $ 1.58 ~ $ 1.68 per share
Click Here For More Historical Outlooks Of Merit Medical Systems, Inc.
Previous Quarter Performance
Merit Medical Systems, Inc. reported income for the second quarter of $ 0.31 per share, from the revenue of $ 218.37 million. The quarterly earnings contracted 26.19 percent while revenues reduced 14.54 percent compared with the same quarter last year.
The consensus estimates are income of $ 0.06 per share from $ 192.67 million in revenue. The bottom line results beat street analysts by $ 0.25 or 416.67 percent, at the same time, top line results outshined analysts by $ 25.70 million or 13.34 percent.
Stock Performance
Shares of Merit Medical Systems, Inc. traded up $ 0.55 or 1.13 percent on Tuesday, reaching $ 49.04 with volume of 409.30 thousand shares. Merit Medical Systems, Inc. has traded high as $ 49.69 and has cracked $ 48.55 on the downward trend
According to the previous trading day, closing price of $ 49.04, representing a 148.67 % increase from the 52 week low of $ 19.50 and a 3.75 % decrease over the 52 week high of $ 50.38.
The company has a market capital of $ 2.72 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Recent Analyst recommendations
- On 28th September 2020, upgraded by Wells Fargo & Co to Equal-Weight from Underweight rating.
Conference Call
Merit Medical Systems, Inc. will be hosting a conference call at 5:00 PM eastern time on 28th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.merit.com
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments.
